<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0"
 xmlns:blogChannel="http://backend.userland.com/blogChannelModule"
>

<channel>
<title>Keyword: insulinpen</title>
<link>https://freerepublic.com/tag/insulinpen/</link>
<description></description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Jul 2026 05:38:41 GMT</lastBuildDate>
<generator>Focus Forum</generator>
<ttl>15</ttl>

<item>
<title>Certain Types of Insulin are in short supply nationwide</title>
<link>https://freerepublic.com/focus/f-chat/4389617/posts</link>
<description>Insulin Glargine Injection (Recombinant)Products Affected - Description Basaglar Tempo Pen subcutaneous injection, Lilly USA, LLC, 100 units/mL, 3 mL pen injector, 5 count, NDC 00002-8214-05 Lantus Solostar Pen subcutaneous injection, Sanofi-Aventis, 100 units/mL, 3 mL pen injector, 5 count, NDC 00088-2219-05 Semglee subcutaneous injection, Biocon, 100 units/mL, 10 mL vial, NDC 83257-0011-11 - discontinued Semglee Pen subcutaneous injection, Biocon, 100 units/mL, 3 mL pen injector, 5 count, NDC 83257-0012-33 - discontinuedReason for the ShortageBiocon discontinued Semglee vials and pens on December 31, 2025. The generic vials and pens are available. Lilly has Basaglar and Rezvoglar Kwikpens available. Lilly is discontinuing...</description>
<author>American Society of Health-System Pharmacists (ASHP)</author>
<comments>https://freerepublic.com/focus/f-chat/4389617/posts#comment</comments>
<pubDate>Tue, 28 Jul 2026 05:38:41 GMT</pubDate>
</item>
</channel>
</rss>